Fibroblast growth factor 21 resistance is associated with body shape in patients with type 2 diabetes complicating hypertension

OBJECTIVES: Obesity, especially abdominal obesity, increases the prevalence of metabolic and cardiovascular disease (CVD). Fibroblast growth factor 21 (FGF21) has been identified as a critical regulator playing a therapeutic role in diabetes and its complications. This study aims to evaluate the rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Jing, Duan, Zikun, Tang, Lu, Liu, Zhen, Tian, Huiying, Wu, Maolan, Bi, Yanxue, Pan, Xingchao, Wang, Wenjun, Gao, Xiaotang, Wang, Ningrui, Lin, Zhuofeng, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325616/
https://www.ncbi.nlm.nih.gov/pubmed/37424900
http://dx.doi.org/10.3389/fcvm.2023.1168047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325616/
https://www.ncbi.nlm.nih.gov/pubmed/37424900
http://dx.doi.org/10.3389/fcvm.2023.1168047

Ejemplares similares